Baylor Institute for Rehabilitation
Dallas, Texas, 75246, United States
Location status: Recruiting
NCT Number: NCT06517459
The purpose of this trial is to examine weight loss for Hispanic/Latino people with stroke (CVA) who take part in a healthy lifestyle program that has been culturally modified for Hispanic/Latino people
Interested in participating?
Request Info18 year–85 year
All sexes
Interventional
Not applicable
Dallas, Texas, 75246, United States
Location status: Recruiting
Weight gain greatly increases the risk of chronic diseases such as diabetes, metabolic syndrome, pulmonary and heart disease. The Group Lifestyle Balance (GLB) intervention is a 12-month, evidence-based weight-loss program that has been used extensively with the general population and with people after CVA, however, it is not adapted to be linguistically and culturally appropriate for Latino persons post stroke. We will modified the program to meet the needs of Latino people with a CVA (GLB-CVA Latino).
Aims:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Group Lifestyle Balance (GLB) program is a self-management intervention that has been shown to result in weight-loss and reduce the risk for Type 2 diabetes through increased physical activity and healthy eating behaviors in the general population. The GLB is a direct adaptation of the Diabetes Prevention Program, both developed at the Diabetes Prevention and Support Center at the University of Pittsburgh. The GLB is designed for delivery in a group-based, community setting,4 and has resulted in weight-loss in a variety of settings, such as community centers, churches, worksites, and healthcare systems.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Weight will be measured during in-person assessments at BSWIR using a Seca 664 scale. Height will be measured using a stadiometer. Weight and height will be used to calculate BMI. A BodyTrace Smart Scale will be provided to participants to facilitate self-weighing in the home, which include cellular connectivity at no cost to participants so weight will be sent directly to the research team.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Fasting venous sample will be obtained for hemoglobin a1c to assess average blood sugar level over the past 2-3 months. Fasting venous samples will also be collected for fasting blood glucose, HDL/LDL, total cholesterol, and triglyceride level. Coordinators are trained phlebotomists
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Fasting venous sample will be obtained for hemoglobin a1c to assess average blood sugar level over the past 2-3 months. Fasting venous samples will also be collected for fasting blood glucose, HDL/LDL, total cholesterol, and triglyceride level. Coordinators are trained phlebotomists
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Fasting venous sample will be obtained for hemoglobin a1c to assess average blood sugar level over the past 2-3 months. Fasting venous samples will also be collected for fasting blood glucose, HDL/LDL, total cholesterol, and triglyceride level. Coordinators are trained phlebotomists
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Waist circumference measured at the umbilicus and mid-upper arm circumference following ACSM guidelines.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Will be collected using a stadiometer and used to calculate BMI
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Using an automatic cuff (average of three readings, patient seated) diastolic and systolic scores will be recorded
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
The Framingham Heart Study diabetes risk score83 will be calculated using predictors including age, gender, fasting glucose, BMI, HDL cholesterol and triglyceride levels, blood pressure, and parental history. Risk score calculator and regression model are free and used in GLB weight-loss trials. The age range for this score is 45 years to 64 years, and therefore only individuals within this age will have calculated scores. Furthermore, the minimum cut-off score is 3.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Assesses distance walked over 6 minutes as a sub-maximal test of aerobic capacity.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Assesses walking speed in (m/s) which is correlated to mobility in the community, capacity to perform ADLs, risk of falls, re-hospitalization, and risk of cognitive decline.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
The BRFSS is a state-based system of health surveys that collects information on health risk behaviors, preventative health practices, and health care access primarily related to chronic disease and injury. The GLB-TBI uses the two subscales of Healthy Eating and Physical Activity from the 2017 version of the BRFSS. It consists of 14 items.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
NEWS assesses participants' perception of neighborhood features related to physical activity and grocery shopping, including residential density, land use mix (including both indices of proximity and accessibility), street connectivity, infrastructure for walking/cycling, neighborhood aesthetics, traffic and crime safety, and neighborhood satisfaction.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Combined word recognition test and comprehension test using multiple-choice questions. Identifies individuals with low health literacy.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Includes 28 items to assess health behaviors among people with disabilities and yields a total Health Practices Score plus 4 subscale scores (Exercise, Nutrition, Health Practices, and Psychological Well Being). Items are rated on a 5-point scale from 0 'not at all' to 4 'completely.' Scores range from 0-28 with higher scores indicating higher self-efficacy for the health behaviors.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Quality of life will be assessed using the Stroke Impact Scale, which assesses 8 dimensions of health-related quality of life specific to people post stroke including subscales (using a 5pt Likert scale) assessing strength, memory and thinking, emotion, communication, activities of daily living, mobility, hand function, and participation/role function.
Time frame: [Time Frame: 12 months]
Participants will be asked to complete an exit survey at the 12-month assessment, asking about experience in, and satisfaction with, the GLB-CVA Latino (including satisfaction and feasibility with modifications and language translation) and suggestions for improvement.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
4 item language based measure of acculturation for Hispanic populations.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Questionnaire that assesses the frequency of support received from others for healthy eating habits over the past 3 months.
Time frame: [Time Frame: Baseline, 3, 6, and 12 months]
Questionnaire that assesses the frequency of support received from others for engaging in physical activity over the past 3 months
Contact information is provided by the study sponsor or research team.
Baylor Research Institute
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05901675
Behavior, Body Weight
Charleston, South Carolina, United States
View Trial DetailsNCT03873467
Behavior, Body Weight
Dallas, Texas, United States
View Trial DetailsNCT00017953
Behavior, Behavioral Symptoms
Birmingham, Alabama, United States
View Trial DetailsNCT07050355
Behavior, Brain Diseases
Durham, North Carolina, United States
View Trial Details